LP-205A1

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameLP-205A1
Drug Alias NameLP-205A1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuroprotectantsCell cycle inhibitors
TargetsUpdating
Therapy Area/IndicationsMetabolic DiseasesCardiovascular DiseasesCentral Nervous System Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLaminar Pharmaceuticals SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLaminar Pharmaceuticals SA
Active IndicationsN/A
Inactive IndicationsMetabolic DiseasesCardiovascular DiseasesCentral Nervous System Diseases +[4] 

Other Information

ATC CodeN/A
Related LinksN/A